1. Home
  2. PRIM vs APGE Comparison

PRIM vs APGE Comparison

Compare PRIM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

HOLD

Current Price

$86.65

Market Cap

4.9B

Sector

Industrials

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$133.98

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRIM
APGE
Founded
1960
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.7B
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
PRIM
APGE
Price
$86.65
$133.98
Analyst Decision
Buy
Strong Buy
Analyst Count
15
13
Target Price
$155.20
$109.67
AVG Volume (30 Days)
1.9M
5.4M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
0.19%
N/A
EPS Growth
51.66
N/A
EPS
0.32
N/A
Revenue
N/A
N/A
Revenue This Year
$9.92
N/A
Revenue Next Year
$8.80
N/A
P/E Ratio
$275.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.00
$34.34
52 Week High
$205.50
$134.32

Technical Indicators

Market Signals
Indicator
PRIM
APGE
Relative Strength Index (RSI) 39.92 80.60
Support Level $65.00 $80.52
Resistance Level $99.29 N/A
Average True Range (ATR) 3.99 0.42
MACD 0.90 -1.40
Stochastic Oscillator 14.13 80.12

Price Performance

Historical Comparison
PRIM
APGE

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: